EANS-General Meeting: Intercell AG / Resolutions of the General Meeting

--------------------------------------------------------------------------------
General meeting information transmitted by euro adhoc. The issuer is
responsible for the content of this announcement.
--------------------------------------------------------------------------------

Intercell AG - Extraordinary General Meeting approved proposed merger of equals
with Vivalis SA to create Valneva SE

Summary of next steps to merger closing

Voting results of Intercell's Extraordinary Shareholders' Meeting as of February
27, 2013

Report on the approval of the proposed merger

Vienna, February 27, 2013 - Intercell AG (Vienna Stock Exchange, ICLL) today
announced that all resolutions were approved by the Extraordinary Shareholders'
Meeting held today. A majority of 97.4% of the represented share capital voted
in favor of the merger to create Valneva SE, a biotech leader in vaccines and
antibodies. The General Meeting of Vivalis SA will take place on March 7, 2013.
As previously announced, the merger is expected to close in May 2013, after
which Valneva SE intends to launch a EUR 40 million capital increase, subject to
regulatory approval.

A total of approximately 33.7% of the outstanding share capital of Intercell AG
was represented in the shareholders meeting.

The resolutions of the Extended Shareholder Meeting included:

*Resolution on the demerger
*Resolution on the cross-border merger
*Resolution on the discharge of the members of the management board for the
period from January 1, 2012 to September 30, 2012
*Resolution on the discharge of the members of the supervisory board for the
period from January 1, 2012 to September 30, 2012
*Resolution on the remuneration of the members of the supervisory board for the
period from January 1, 2012 to September 30, 2012

For further details about the resolutions please see www.intercell.com.

Further inquiry note:
Intercell AG
Nina Waibel
Corporate Communications
Tel. +43 1 20620-1222
[email protected]
end of announcement euro adhoc
--------------------------------------------------------------------------------

issuer:      Intercell AG
             Campus Vienna Biocenter  3
             A-1030 Wien 
phone:       +43 1 20620-0
FAX:         +43 1 20620-800
mail:        [email protected] 
WWW:         www.intercell.com
sector:      Biotechnology
ISIN:        AT0000612601
indexes:     ATX Prime

stockmarkets: official market: Wien
language: English

ORIGINAL APA-OTS TEXT - THE INFORMATION CONTAINED IN THIS PRESS RELEASE IS SUBJECT TO THE EXCLUSIVE RESPONSIBILITY OF THE ISSUER | EAE

print